Drug Shortage Report for BOOSTRIX
Report ID | 179831 |
Drug Identification Number | 02247600 |
Brand name | BOOSTRIX |
Common or Proper name | Combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine for booster vaccination |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID TETANUS TOXOID DIPHTHERIA TOXOID |
Strength(s) | 2.5MCG 8MCG 8MCG 20UNIT 2UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10s |
ATC code | J07AX |
ATC description | BACTERIAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-01-03 |
Estimated end date | 2023-05-16 |
Actual end date | 2023-05-15 |
Shortage status | Resolved |
Updated date | 2023-05-16 |
Company comments | Supply unavailable |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-01-04 | English | Compare |
v2 | 2023-01-04 | French | Compare |
v3 | 2023-03-23 | English | Compare |
v4 | 2023-03-23 | French | Compare |
v5 | 2023-05-10 | English | Compare |
v6 | 2023-05-10 | French | Compare |
v7 | 2023-05-16 | English | Compare |
v8 | 2023-05-16 | French | Compare |
Showing 1 to 8 of 8